THE VARIATION OF T-CELL RECEPTORS (TCR) DIVERSITY AND GENOMIC HUMAN LEUKOCYTE ANTIGEN (HLA-I) AMONG NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS EXPRESSING HIGH PDL-1 (>= 50%) VERSUS THOSE WITH LOW OR NO PDL1 (<50%)

Aaron Beasley; Anna Reid; Leslie Calapre; Michael Millward; Elin Gray; Afaf Abed

doi:10.1136/jitc-2022-SITC2022.0577

THE VARIATION OF T-CELL RECEPTORS (TCR) DIVERSITY AND GENOMIC HUMAN LEUKOCYTE ANTIGEN (HLA-I) AMONG NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS EXPRESSING HIGH PDL-1 (>= 50%) VERSUS THOSE WITH LOW OR NO PDL1 (<50%)

Aaron Beasley, Anna Reid, Leslie Calapre, Michael Millward, Elin Gray, Afaf Abed

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	A603-A603
Number of pages	1
Journal	Journal for ImmunoTherapy of Cancer
Volume	10
DOIs	https://doi.org/10.1136/jitc-2022-SITC2022.0577
Publication status	Published - Nov 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/jitc-2022-SITC2022.0577

Cite this

Beasley, A., Reid, A., Calapre, L., Millward, M., Gray, E., & Abed, A. (2022). THE VARIATION OF T-CELL RECEPTORS (TCR) DIVERSITY AND GENOMIC HUMAN LEUKOCYTE ANTIGEN (HLA-I) AMONG NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS EXPRESSING HIGH PDL-1 (>= 50%) VERSUS THOSE WITH LOW OR NO PDL1 (<50%). Journal for ImmunoTherapy of Cancer , 10, A603-A603. https://doi.org/10.1136/jitc-2022-SITC2022.0577

@article{2f12b587ee2c46a1b96840c6e8317d74,

title = "THE VARIATION OF T-CELL RECEPTORS (TCR) DIVERSITY AND GENOMIC HUMAN LEUKOCYTE ANTIGEN (HLA-I) AMONG NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS EXPRESSING HIGH PDL-1 (>= 50%) VERSUS THOSE WITH LOW OR NO PDL1 (<50%)",

author = "Aaron Beasley and Anna Reid and Leslie Calapre and Michael Millward and Elin Gray and Afaf Abed",

year = "2022",

month = nov,

doi = "10.1136/jitc-2022-SITC2022.0577",

language = "English",

volume = "10",

pages = "A603--A603",

journal = "Journal for ImmunoTherapy of Cancer ",

issn = "2051-1426",

publisher = "BMJ Group",

}

Beasley, A, Reid, A, Calapre, L, Millward, M, Gray, E & Abed, A 2022, 'THE VARIATION OF T-CELL RECEPTORS (TCR) DIVERSITY AND GENOMIC HUMAN LEUKOCYTE ANTIGEN (HLA-I) AMONG NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS EXPRESSING HIGH PDL-1 (>= 50%) VERSUS THOSE WITH LOW OR NO PDL1 (<50%)', Journal for ImmunoTherapy of Cancer , vol. 10, pp. A603-A603. https://doi.org/10.1136/jitc-2022-SITC2022.0577

THE VARIATION OF T-CELL RECEPTORS (TCR) DIVERSITY AND GENOMIC HUMAN LEUKOCYTE ANTIGEN (HLA-I) AMONG NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS EXPRESSING HIGH PDL-1 (>= 50%) VERSUS THOSE WITH LOW OR NO PDL1 (<50%). / Beasley, Aaron; Reid, Anna; Calapre, Leslie et al.
In: Journal for ImmunoTherapy of Cancer , Vol. 10, 11.2022, p. A603-A603.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - THE VARIATION OF T-CELL RECEPTORS (TCR) DIVERSITY AND GENOMIC HUMAN LEUKOCYTE ANTIGEN (HLA-I) AMONG NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS EXPRESSING HIGH PDL-1 (>= 50%) VERSUS THOSE WITH LOW OR NO PDL1 (<50%)

AU - Beasley, Aaron

AU - Reid, Anna

AU - Calapre, Leslie

AU - Millward, Michael

AU - Gray, Elin

AU - Abed, Afaf

PY - 2022/11

Y1 - 2022/11

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000919423400541

U2 - 10.1136/jitc-2022-SITC2022.0577

DO - 10.1136/jitc-2022-SITC2022.0577

M3 - Abstract/Meeting Abstract

SN - 2051-1426

VL - 10

SP - A603-A603

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

ER -

Beasley A, Reid A, Calapre L, Millward M, Gray E, Abed A. THE VARIATION OF T-CELL RECEPTORS (TCR) DIVERSITY AND GENOMIC HUMAN LEUKOCYTE ANTIGEN (HLA-I) AMONG NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS EXPRESSING HIGH PDL-1 (>= 50%) VERSUS THOSE WITH LOW OR NO PDL1 (<50%). Journal for ImmunoTherapy of Cancer . 2022 Nov;10:A603-A603. doi: 10.1136/jitc-2022-SITC2022.0577

THE VARIATION OF T-CELL RECEPTORS (TCR) DIVERSITY AND GENOMIC HUMAN LEUKOCYTE ANTIGEN (HLA-I) AMONG NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS EXPRESSING HIGH PDL-1 (>= 50%) VERSUS THOSE WITH LOW OR NO PDL1 (<50%)

UN SDGs

Access to Document

Other files and links

Cite this